nach oben

European Archives of Psychiatry and Clinical Neuroscience

Erschienen in:

01.02.2007 | ORIGINAL PAPER

Insight and regional brain volumes in schizophrenia

verfasst von: Débora Pastore Bassitt, Mario Rodrigues Louzã Neto, Cláudio Campi de Castro, Geraldo F. Busatto

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

We have investigated the relationship between insight impairment and regional brain volumes (gray and white matter) in schizophrenia using voxel-based morphometry (VBM). Fifty patients with schizophrenia were evaluated using the Scale for Unawareness of Mental Disorders. Magnetic resonance images were acquired, segmented and spatially normalized using optimized VBM routines. No significant inverse correlations were detected between insight impairment and gray or white matter volumes in the prefrontal region (where significant findings had been predicted a priori), or in any other brain areas. Our results do not support previous hypotheses suggesting a relationship between frontal lobe atrophy and impaired insight in patients with schizophrenia.

Amador X, David A (eds) (2004) Insight and Psychosis: awareness of illness in schizophrenia and related disorders. 2nd Ed. Oxford University Press, London

Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, Pham D, Kumar A (2004) Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiat 161:99–108PubMedCrossRef

Bookstein FL (2001) Voxel-based morphometry should not be used with imperfectly registered images. Neuroimage 14:1454–1462PubMedCrossRef

Brett M, Jonhsrude IS, Owen AM (2002) The problem of functional localization in the human brain. Nat Rev Neurosci 3:243–249PubMedCrossRef

David A, VanOs J, Jones P, Harvey I, Foester A, Fahy T (1995) Insight and psychotic illness: cross-sectional and longitudinal associations. Br J Psychiatry 167:621–628PubMedCrossRef

Drake RJ, Lewis W (2003) Insight and neurocognitive deficits in schizophrenia. Schizophr Res 62:165–173PubMedCrossRef

Flashman LA, McAllister TW, Andreasen NC, Saykin AJ (2000) Smaller brain size associated with unawareness of illness in patients with schizophrenia. Am J Psychiat 157:1167–1169PubMedCrossRef

Flashman LA, McAllister TW, Johnson SC, Rick JH, Green RL, Saykin AJ (2001) Specific frontal lobe subregions correlated with unawareness of illness in schizophrenia: a preliminary study. J Neuropsychiat Clin Neurosci 13:255–257

Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD (1996) Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 4:223–235PubMedCrossRef

10.

Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21–36PubMedCrossRef

11.

Kirkbride JB, Fearon P, Morgan C, Dazzan P, Morgan K, Tarrant J, Lloyd T, Holloway J, Hutchinson G, Leff JP, Mallett RM, Harrison GL, Murray RM, Jones PB (2006) Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiat 63:250–258PubMedCrossRef

12.

Larøoi F, Fannemel M, Røonneberg U, Flekkøoy K, Opjordsmoen S, Dullerud R, Haakosen M (2000) Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiat Res: Neuroimag Sect 100:49–58CrossRef

13.

Lysaker P, Lancaster MS, Davis LW, Clements CA (2003) Patterns of neurocognitive deficits and unawareness of illness in schizophrenia. J Nerv Ment Dis 191:38–44PubMedCrossRef

14.

Lysaker PH, Bell MD, Bryson GJ, Kaplan E (1998) Insight and interpersonal function in schizophrenia. J Nerv Ment Dis 186:432–436PubMedCrossRef

15.

McCormick L, Decker L, Nopoulos P, Ho BC, Andreasen N (2005) Effects of atypical and typical neuroleptics on anterior cingulate volume in schizophrenia. Schizophr Res 80:73–84 PubMedCrossRef

16.

Mintz AR, Dobson KS, Romney DM (2003) Insight in schizophrenia: a meta-analysis. Schizophr Res 61:75–88PubMedCrossRef

17.

Moorhead TW, Job DE, Whalley HC, Sanderson TL, Johnstone EC, Lawrie SM (2004) Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods. Neuroimage 22:188–202PubMedCrossRef

18.

Rossel SL, Coakes J, Shapleske J, Woodruff PWR, David AS (2003) Insight: its relationship with cognitive function, brain volume and symptoms in schizophrenia. Psychol Med 33:111–119CrossRef

19.

Shad MU, Muddasani S, Prasad K, Sweeney JA, Keshavan MS (2004) Insight and prefrontal cortex in first-episode Schizophrenia. Neuroimage 22:1315–1320PubMedCrossRef

20.

Smith TE, Hull JW, Israel LM, Willson DF (2000) Insight, symptoms, and neurocognition in schizophrenia and schizoaffective disorder. Schizophr Bull 26:193–200PubMed

21.

Tailarach J, Tounoux P (1988) Co-planar stereotaxic atals of the human brain. George Thieme Verlag, New York

22.

Takai A, Uematsu M, Ueki H, Sone K, Kaiya H (1992) Insight and its related factors in chronic schizophrenic patients: a preliminary study. Eur J Psychiat 6:159–17

23.

Tzourio-Mazoyer N, De Schonen S, Crivello F, Reutter B, Aujard Y, Mazoyer B (2002) Neural correlates of woman face processing by 2-month-old infants. Neuroimage 15:454–61PubMedCrossRef

24.

Zald DH, Kim SW (1996) Anatomy and function of the orbital frontal cortex, I: anatomy, neurocircuitry; and obsessive-compulsive disorder. J Neuropsychiat Clin Neurosci 8(2):125–38

Titel: Insight and regional brain volumes in schizophrenia
verfasst von: Débora Pastore Bassitt
Mario Rodrigues Louzã Neto
Cláudio Campi de Castro
Geraldo F. Busatto
Publikationsdatum: 01.02.2007
Verlag: Steinkopff-Verlag
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 1/2007
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI: https://doi.org/10.1007/s00406-006-0685-z

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2007

Predicting treatment outcome on three measures for post-traumatic stress disorder

Cerebral atrophy and white matter disruption in chronic schizophrenia

Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders

Brain-derived neurotrophic factor (BDNF) polymorphisms G196A and C270T are not associated with response to electroconvulsive therapy in major depressive disorder

Deficit of social cognition in subjects with surgically treated frontal lobe lesions and in subjects affected by schizophrenia